Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Tandem Diabetes Care Announces Upcoming Conference Presentation
-
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference
-
Next Bridge Hydrocarbons Releases Share Registration Data
-
Net Asset Value(s)
-
ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly
-
ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly
-
Pasqal to Participate in Upcoming Investor Conferences
-
Exagen Inc. to Participate in Upcoming Investor Conference
-
AngioDynamics to Participate in Upcoming Investor Conferences
-
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
-
QuickLogic to Report Second Quarter 2026 Financial Results on Tuesday, August 11 and Participate in Key Investor Conferences in the Third Quarter
-
SharkNinja to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Form 8.3 - [ANIMALCARE GROUP PLC - 27 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 27 07 2026] - (CGWL)
-
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
-
Entera Bio prices $275M private placement led by BVF Partners
-
Entera Bio prices $275 million private placement led by BVF Partners
-
CoinShares CEO Jean-Marie Mognetti to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference in Boston
-
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
-
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
-
AtriCure to Participate at Upcoming Investor Conferences
-
PPHC to Report Second Quarter 2026 Financial Results and Present at Upcoming Investor Conference
-
Form 8.3 - [ANIMALCARE GROUP PLC - 24 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 24 07 2026] - (CGWL)
-
Phoenix Metals Corp. Announces Partial Exercise of Over-Allotment Option
-
Form 8.3- [ANIMALCARE GROUP PLC - 23 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 23 07 2026] - (CGWL)
-
Nevada Sunrise Closes $1.055 Million Private Placement
-
Brompton Split Banc Corp. Completes Preferred Share Offering
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 22 07 2026] - (CGWL)
-
Empire Metals Limited Announces Management Appointments
-
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
-
Fractyl Health to Participate in Upcoming Investor Events
-
ArcStone Kingswood Names Karen Sterling, PhD, CFA Head of Biotechnology Investment Banking
-
Valeura Energy Inc. Announces Revolving and Expandable Credit Facility
-
TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
-
Perion Announces Participation in Leading Investor Conferences in August and September 2026
-
Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Form 8.3 - [APTITUDE SOFTWARE GROUP PLC - 21 07 2026] - (CGAML)
-
Form 8.3 - [ANIMALCARE GROUP PLC - 21 07 2026} - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 21 07 2026] - (CGWL)
-
CleanTech Vanadium raises $433K in first tranche of private placement
-
CleanTech Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of $433,033
-
Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference
-
Chairman Transition and Board Changes
-
Correction: Net Asset Value(s)
-
Net Asset Value(s)
-
The Honest Company Announces Strategic Leadership Updates Across Finance and Investor Relations

